Merging Systems Biology with Pharmacodynamics
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Enhanced pharmacodynamic models combine favorable features of systems biology and traditional models and may form the basis of precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Network motifs: simple building blocks of complex networks.
Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., & Alon, U. (2002) · Science · doi:10.1126/science.298.5594.824 · Cited by 7,368 · cited 1×
“Such trends enable network analyses to map the topology of biological systems ( 6 ) and to construct dynamic ordinary diff erential equation (ODE) models that represent biochemical reaction mechanisms from ligand-receptor binding to cell outputs ( 2 , 7 ). ese are plausible consensus models that…”
BackgroundCan the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Emergent Properties of Networks of Biological Signaling Pathways
Bhalla, U. S., & Iyengar, R. (1999) · Science · doi:10.1126/science.283.5400.381 · Cited by 1,686 · cited 1×
“Systems biology provides a broad perspective of cellular-and tissue-level events that requires the application of quantitative tools and computational models ( 2 ) to develop and study the functional capabilities of molecular networks ( 3 , 4 ).”
BackgroundSelf-citationDrug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
Physicochemical modelling of cell signalling pathways
Aldridge, B. B., Burke, J. M., Lauffenburger, D. A., & Sorger, P. K. (2006) · Nature Cell Biology · doi:10.1038/ncb1497 · Cited by 592
Modeling the interactions between osteoblast and osteoclast activities in bone remodeling
Lemaire, V., Tobin, F. L., Greller, L. D., Cho, C. R., & Suva, L. J. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.03.023 · Cited by 452
Pharmacokinetic/Pharmacodynamic Modeling in Drug Development
Sheiner, L. B., & Steimer, J.-L. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.67 · Cited by 351
MAHMOOD, I. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.015 · Cited by 170
Cited by
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“ML algorithms replace the chemical similarity and molecular docking-based conventional methods with new system biology methods, which can evaluate drug effects [270–273].”
MethodZhang, X., Trame, M., Lesko, L., & Schmidt, S. (2015) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.6 · Cited by 467
“This type of PK/ePD modeling has numerous advantages in incorporating the details of single or multiple drug concentrations, systems biology models, the pertinent regulatory networks and motifs of feedback/feed forward loops, individual genomic and epigenetic characteristics, which has made the individual patient ther…”
BackgroundWorkgroup, E. M., Marshall, S., Burghaus, R., Cosson, V, Cheung, S., Chenel, M., DellaPasqua, O., Frey, N., Hamrén, B., Harnisch, L., et al. (2016) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12049 · Cited by 373
Machine Learning in Pharmacometrics: Opportunities and Challenges
McComb, M., Bies, R., & Ramanathan, M. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14801 · Cited by 128
“17 QSP models can have hundreds of compartments representing DNA, mRNA, protein and metabolite levels that are interconnected based on pharmacological knowledge of the activation and inhibition patterns that occur in signalling pathways of interest.”
BackgroundSystems pharmacology for drug discovery and development: paradigm shift or flash in the pan?
Vicini, P., & van der Graaf, P. H. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.40 · Cited by 108
Metadata
- Authors
- Iyengar, R., Zhao, S., Chung, S.-W., Mager, D. E., & Gallo, J. M.
- Venue
- Science Translational Medicine
- Published
- 2012-03-21
- Volume
- 4
- Issue
- 126
- Pages
- 126ps7-126ps7
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2109477330
- Cited by
- 156
- References
- 9
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Merging Systems Biology with Pharmacodynamics. https://app.cochat.ai/papers/10.1126/scitranslmed.3003563
- The paper
- Iyengar, R., Zhao, S., Chung, S.-W., Mager, D. E., & Gallo, J. M. (2012). Merging Systems Biology with Pharmacodynamics. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3003563
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.